异戊酰紫草素 | 76549-35-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 异戊酰紫草素
• 英文名称: shikonin isovalerate
• 英文别名: isovalerylshikonin；isovaleryl shikonin；Isovaleryl-alkannin；[1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] 3-methylbutanoate
• CAS: 76549-35-4
• 化学式: C₂₁H₂₄O₆
• 分子量: 372.418
• InChiKey: UTOUNDHZJFIVPK-UHFFFAOYSA-N

物化性质

• 沸点：
  570.1±50.0 °C(Predicted)
• 密度：
  1.246±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  27
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  101
• 氢给体数：
  2
• 氢受体数：
  6

安全信息

• 海关编码：
  2915900090
• 储存条件：
  存储条件：2-8°C，干燥，密封。

反应信息

• 作为产物：
  描述：

  紫朱牛舌草(ALKANNATINCTORIA)根提取物 、 异戊酰氯 在 盐酸 作用下， 以 苯 为溶剂， 生成 异戊酰紫草素
  参考文献：
  名称：

  Afzal, M.; Al-Hrif, M. T., Journal fur praktische Chemie (Leipzig 1954), 1982, vol. 324, # 5, p. 865 - 869

  摘要：

  DOI：

文献信息

• Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizo dor treating or preventing diabetes mellitus and the use thereof
  申请人：Park Ji Ho

  公开号：US20090318552A1

  公开（公告）日：2009-12-24

  The present invention relates to a composition for preventing and treating diabetes mellitus that includes a shikonin compound as an active ingredient and to a use thereof. More particularly, the present invention relates to a composition for preventing and treating diabetes mellitus that includes isobutyryl shikonin, β,β-dimethylacryl shikonin, isovaleryl shikonin, or α-methyl-n-butyryl shikonin as an active ingredient and to a use thereof. The composition of the present invention exhibits antidiabetic effects by blocking the K ATP ion channels (ATP-sensitive potassium ion channels) of beta (β) cells in the pancreas and increasing the concentration of calcium ions to promote the secretion of insulin, and thus can be used as a medicinal pharmaceutical, food additive, or health functional food for preventing and treating diabetes mellitus.
• Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof
  申请人：Park Ji Ho

  公开号：US20100093852A1

  公开（公告）日：2010-04-15

  The present invention relates to a composition comprising shikonin compounds, especially, isobutyryl shikonin, β-β-dimethylacryl shikonin, isovaleryl shikonin, and α-methyl-n-butyryl shikonin as an active ingredient for the prevention and treatment of diabetes mellitus and the use thereof. The composition of the present invention showed stimulating effect on the release of insulin in the beta cell of the pancreas due to inhibitory effect on K ATP ion channel of beta cell in pancreas together with promoting effect on the increase of calcium concentration. Therefore, it can be used as the therapeutics, health functional food or food additive for treating and preventing diabetes mellitus.
• Afzal, M.; Al-Hrif, M. T., Journal fur praktische Chemie (Leipzig 1954), 1982, vol. 324, # 5, p. 865 - 869
  作者：Afzal, M.、Al-Hrif, M. T.

  DOI：——

  日期：——